TG Therapeutics TGTX Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $447.18M+1,812% | $23.38M— | —— | -$223.81M+35.7% | ||
| $59K-13.2% | $68K-67.8% | $211K-30.4% | $303K+7.4% | ||
| $64.67M+52.0% | $42.54M+12.1% | $37.93M-15.0% | $44.65M-27.1% | ||
| —— | —— | —— | -$176.17M+40.4% | ||
| $214K+376% | $45K— | —— | $14K-96.5% | ||
| —— | —— | -$50.65M— | —— | ||
| $91.24M+942% | $8.76M— | —— | $0— | ||
| —— | —— | —— | $0-100% | ||
| -$90.79M-167% | $134.6M+85.1% | $72.71M— | —— | ||
| -$105.78M— | —— | —— | -$196.57M+22.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does TG Therapeutics generate?
- TG Therapeutics (TGTX) generated -$95.4M in operating cash flow over the trailing twelve months.
- What is TG Therapeutics's free cash flow?
- After $240.0K of capital expenditures, TG Therapeutics's free cash flow was -$95.6M over the trailing twelve months, down 66.2% year over year.
- Where does TG Therapeutics's cash flow data come from?
- Every line is extracted from TG Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
